» Articles » PMID: 1592528

Loss of HLA Class-I Alleles, Heavy Chains and Beta 2-microglobulin in Colorectal Cancer

Overview
Journal Int J Cancer
Specialty Oncology
Date 1992 May 28
PMID 1592528
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Using immunohistochemical methods, we have analysed colorectal biopsies of normal mucosa, metaplastic polyps (5 cases), adenomas (15 cases) and adenocarcinomas (70 cases) with 13 monoclonal antibodies (MAbs) to allelic products of the HLA-A, B, C loci. Nine of the 70 carcinomas showed total loss of HLA Class-I molecules due to an underlying defect regarding not only the expression of beta 2-microglobulin (beta 2-m), but also the heavy chains of HLA A, B and C loci, or both. Much commoner was a loss of one or more Class-I alleles as follows: A1/Aw36 (completely lost in 4 of 29 cases and focally lost in another 2), A2 (in 1 of 37 cases), A3 (in 2 of 14 cases), A1 1/28/31/33 (in 3 of 11 cases), B7 (in 3 of 13 and focally in 1 other case), B17 (in 1 case), Bw4 (in 8 of 45 and focally in another 6), Bw6 (in 9 of 62 and focally in another 3). Focal selective loss (Bw6 and a combined A1-Bw6), was observed in 2 adenomas. Normal colonic mucosa, as well as stromal and lymphoid cells present between the neoplastic glands, were studied in each case as a control. A particular allele was only considered to be lost by the malignant cells if it was still expressed on these adjacent tissues.

Citing Articles

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Dhatchinamoorthy K, Colbert J, Rock K Front Immunol. 2021; 12:636568.

PMID: 33767702 PMC: 7986854. DOI: 10.3389/fimmu.2021.636568.


HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Anderson P, Aptsiauri N, Ruiz-Cabello F, Garrido F Cell Mol Immunol. 2021; 18(3):556-565.

PMID: 33473191 PMC: 8027055. DOI: 10.1038/s41423-021-00634-7.


Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer.

Goeppert B, Frauenschuh L, Zucknick M, Roessler S, Mehrabi A, Hafezi M Br J Cancer. 2015; 113(9):1343-9.

PMID: 26461054 PMC: 4815783. DOI: 10.1038/bjc.2015.337.


The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?.

Powell A, Horgan P, Edwards J J Cancer Res Clin Oncol. 2012; 138(5):723-8.

PMID: 22426959 DOI: 10.1007/s00432-012-1192-4.


Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.

Schietinger A, Philip M, Liu R, Schreiber K, Schreiber H J Exp Med. 2010; 207(11):2469-77.

PMID: 20921286 PMC: 2964573. DOI: 10.1084/jem.20092450.